BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20150329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20151025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170210
DTEND;VALUE=DATE:20170311
DTSTAMP:20170210T232921Z
CREATED:20170210T232735Z
LAST-MODIFIED:20170210T232921Z
UID:17651-1486684800-1489190399@ces.b2sg.org
SUMMARY:Postdoctoral Fellow in Cancer Epigenetics at Beckman Research Institute
DESCRIPTION:Job Title:  Postdoctoral Fellow – Yu Lab \n  \nPosition Summary and Key Responsibilities: \nPostdoctoral positions are available to work in the areas of chromatin remodeling\, epigenetic modifications\, DNA damage response and tumor suppression (Nature 493:561-564; Cancer Cell 23:693-704; Mol. Cell 49:897-907; Genes Dev. 27:1752-1768; Genome Res. 24:570-579). The approaches we take range from mammalian cell culture\, molecular biology\, biochemistry to mouse genetics. A strong background in biochemistry and molecular cell biology is essential. Experience with bioinformatics\, mass spectrometry and mouse model analysis is desirable. We are seeking candidates who are self-motivated and career-oriented. The research environment is outstanding at Beckman Research Institute. Applications should send curriculum vitae\, the names and email addresses of three references to: \n  \nXiaochun Yu\, M.D.\, Ph.D. \nDepartment of Cancer Genetics and Epigenetics \nBeckman Research Institute \nCity of Hope National Medical Center \n1500 E Duarte Rd.\, Duarte\, CA 91741 \nEmail: xyu@coh.org. \n  \nMinimum Education and Skills Required for Consideration: \n• A Ph.D. degree in life or biomedical sciences\, or a related discipline is required. \n  \nAbout City of Hope \nCity of Hope\, an innovative biomedical research\, treatment and educational institution with over 4000 employees\, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate\, patient-centered philosophy. Founded in 1913 and headquartered in Duarte\, California\, City of Hope is a remarkable non-profit institution\, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network\, an alliance of the nation’s 20 leading cancer centers that develops and institutes standards of care for cancer treatment. \nCity of Hope is an equal opportunity employer.  All qualified applicants will receive consideration for employment without regard to race\, religion\, color national origin\, sex\, age\, status as a protected veteran\, or status as a qualified individual with disability.
URL:https://ces.b2sg.org/event/postdoc-bri/
LOCATION:Beckman Research Institute\, 1500 E Duarte Rd.\, Duarte\, CA\, 91741\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/02/City-of-hope.png
ORGANIZER;CN="Department of Cancer Genetics and Epigenetics":MAILTO:xyu@coh.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20161130
DTEND;VALUE=DATE:20161203
DTSTAMP:20160105T223856Z
CREATED:20151230T052431Z
LAST-MODIFIED:20160105T223856Z
UID:12209-1480464000-1480723199@ces.b2sg.org
SUMMARY:4th Max Planck Freiburg Epigenetics Meeting
DESCRIPTION:With the 1st Max Planck Freiburg Epigenetics Meeting in 2010\, we celebrated the establishment of the epigenetic focus at our institute and launched a biennial conference series on epigenetics. \nWe are committed to create an exceptional environment for epigenetic research in Freiburg and we would be very happy if you contributed by sharing your exciting data and novel ideas at the 4th international event which will take place from November 30 to December 2\, 2016. A group of high-profile speakers will be assembled\, representing a broad range of topics in the field of chromatin and epigenetics. We look forward to welcoming you in Freiburg. \nThe programme will include invited and selected talks and give ample time for poster presentations. \nPractical information: \nRegistration will be from 1 April 2016 to 31 August 2016. \nNotification of acceptance for the meeting: 30 September 2016. \nDeadline for payment: 15 October 2016 \nThe conference will take place at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg/Germany\, a medieval city nestled between the famous Black Forest and the vineyards of the Kaiserstuhl.
URL:https://ces.b2sg.org/event/4th-max-planck-freiburg-epigenetics-meeting/
LOCATION:Unnamed Venue\, Freiburg\, Germany
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/MaxPlanck.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20161102
DTEND;VALUE=DATE:20161105
DTSTAMP:20160426T203214Z
CREATED:20160426T201256Z
LAST-MODIFIED:20160426T203214Z
UID:15348-1478044800-1478303999@ces.b2sg.org
SUMMARY:abcam: Stem Cell and Higher-Order Chromatin Structure conference
DESCRIPTION:Present\, learn and collaborate! Present your work and find out the latest news. \nTopics \n\n\n\n\n\n\n\n\n\n\n\n\n\nCoding and non-coding functions of the genome\nChromatin structure in stem cells\nGenome architecture and human disease\n\nDescription \nStem cells have the unique properties of both self renewal and differentiation into various lineages. In the last few years\, chromatin architecture and noncoding RNAs are emerging as major players in both gene regulation and  stem cell differentiation. This conference will cover some of the most recent advances and cutting edge research in the field of chromatin organization\, transcription regulation and stem cell biology. We aim to provide a forum in which interdisciplinary discussions will promote cross-collaboration between experts in these areas. Moreover\, during the meeting\, there will be great opportunities for young scientists to meet the experts in the field.
URL:https://ces.b2sg.org/event/abcam-stem-cell-and-higher-order-chromatin-structure-conference/
LOCATION:Taormina Palazzo dei Congressi\, Sicily\, Italy
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/abcam1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20161101
DTEND;VALUE=DATE:20161105
DTSTAMP:20160426T185017Z
CREATED:20160426T184918Z
LAST-MODIFIED:20160426T185017Z
UID:15333-1477958400-1478303999@ces.b2sg.org
SUMMARY:Wellcome Genome Campus: Epigenomics of Common Diseases 2016
DESCRIPTION:The 6th Epigenomics of Common Diseases conference will bring together leading scientists from the fields of epigenomics\, genetics and bioinformatics to discuss the latest developments in this fast-moving area. \nEpigenetic variation plays an important role in disease processes and provides a promising focus for disease prediction\, prevention and treatment. Technological advancements in the past few years have fuelled a dramatic increase in the scale\, breadth and availability of epigenomic reference data. In addition\, novel developments such as single cell analysis and gene editing present exciting new opportunities. Associations between epigenetic variation\, a variety of risk factors and the development of many diseases continue to emerge but causality has\, in many instances\, not yet been established. \nThis meeting will focus on epigenomic studies across of a wide range of common and other diseases including cancer\, and will include approaches from a variety of different disciplines. It will explore technological and methodological developments and provide a forum to present and discuss recent advances in epigenomics of relevance to human disease.
URL:https://ces.b2sg.org/event/wellcome-genome-campus-epigenomics-of-common-diseases-2016/
LOCATION:Wellcome Genome Campus\, Hinxton\, Camebridge\, United Kingdom
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/Wellcome-Genome-Campus.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20161019
DTEND;VALUE=DATE:20161022
DTSTAMP:20160426T200648Z
CREATED:20160426T200648Z
LAST-MODIFIED:20160426T200648Z
UID:15345-1476835200-1477094399@ces.b2sg.org
SUMMARY:Chromatin\, Replication and Chromosomal Stability 2016
DESCRIPTION:The fourth meeting in the Chromatin Replication series will explore new ideas on the interplay between chromosome organization\, epigenetic inheritance and genome duplication.\n \nTopics \n\n\n\n\n\n\n\n\n\n\n\n\n\n​Mechanisms of DNA replication\nHow to replicate chromosomes\nCell division and epigenetic plasticity\nEpigenome inheritance and reprogramming\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe epigenetic framework guides events like replication\, repair and transcription\, which in turn themselves leave an imprint on chromatin and chromosomal structure. Understanding how modulation of chromatin during replication and repair influence cell fate decisions in normal development and disease represents a major challenge. By bringing together leading scientists in chromatin\, replication\, and epigenetics\, this conference aims to inspire discussions and new ideas on the interplay between chromosome organisation\, epigenetic inheritance and genome duplication.
URL:https://ces.b2sg.org/event/chromatin-replication-and-chromosomal-stability-2016/
LOCATION:University of Copenhagen\, Denmark
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/abcam1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20161005
DTEND;VALUE=DATE:20161009
DTSTAMP:20160625T123750Z
CREATED:20151230T051822Z
LAST-MODIFIED:20160625T123750Z
UID:12207-1475625600-1475971199@ces.b2sg.org
SUMMARY:Danube Scientific Conference on Epigenetics
DESCRIPTION:In the last couple of years the word epigenetics became used in several meanings. \nThis meeting will try to review the concepts of epigenetics\, the current state of the research in this field and the research methods of the field. Beside this we plan to be a meeting forum for the researchers and clinicians who are studying or planning to study topics in the field of epigenetics. \nWe plan to put forward those topics that deal mainly with the covalent modifications of the chromatin (DNA methylation and histone tail modifications) and their consequences especially those that define the transcriptional possibilities of a cell in a specific chromatin context. \nPlease join us at the meeting! We encourage everybody to submit an abstract. The results can be presented on posters or by talks\, most of which will be selected from the submitted abstracts.
URL:https://ces.b2sg.org/event/danube-scientific-conference-on-epigenetics/
LOCATION:Unnamed Venue\, Dudapest\, Hungary
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/Danube-Scientific-Conference-on-Epigenetics.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160926
DTEND;VALUE=DATE:20160927
DTSTAMP:20160426T215402Z
CREATED:20160426T194422Z
LAST-MODIFIED:20160426T215402Z
UID:15340-1474848000-1474934399@ces.b2sg.org
SUMMARY:abcam: Boston Chromatin Snapshot Series
DESCRIPTION:This event will be free of charge for all attendees but early registration is required. Space is limited so early registration is recommended. Registration will close 1 September 2016.\nEpigenetics and Chromatin are playing fundamental roles in the development of organisms as well as the development of pathologies\, such as cancer. This series of meetings will aim to bring together both the scientists studying the fundamentals of chromatin and epigenetics\, and those scientists studying specific systems or diseases that chromatin dynamics could be impacting. We hope that this journal club will inspire dialog\, lots of questions\, future collaborations\, and most of all\, energetic exchange. The meeting will have at least two keynote speakers and a selection of talks from trainees (e.g.\, graduate students and postdoctoral fellows).
URL:https://ces.b2sg.org/event/abcam-boston-chromatin-snapshot-series/
LOCATION:Joseph B. Martin Conference Center\, 77 Avenue Louis Pasteur\, Boston\, MA\,  02115\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/abcam1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160919
DTEND;VALUE=DATE:20160923
DTSTAMP:20160426T185859Z
CREATED:20160426T185520Z
LAST-MODIFIED:20160426T185859Z
UID:15334-1474243200-1474588799@ces.b2sg.org
SUMMARY:Wellcome Genome Campus: Genome Informatics conference
DESCRIPTION:This 16th Genome Informatics conference will focus on large-scale approaches to understanding the structure and biology of genomes. Biology is an experimental science that is experiencing an explosion of new data. This requires biologists to increase the scale and sophistication of the information technology used for their research. \nThe conference scope encompasses a wide range of methods for the analysis of these data\, including a focus on technologies such as variant-calling\, transcriptomic analysis\, and variant interpretation\, applied to very large genomic data sets. This meeting alternates between Hinxton\, UK and Cold Spring Harbor\, New York.
URL:https://ces.b2sg.org/event/wellcome-genome-campus-advanced-courses-and-scientific-conferences-genome-informatics-2016/
LOCATION:Wellcome Genome Campus\, Hinxton\, Camebridge\, United Kingdom
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/Wellcome-Genome-Campus.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160914
DTEND;VALUE=DATE:20160917
DTSTAMP:20160426T184342Z
CREATED:20160426T183029Z
LAST-MODIFIED:20160426T184342Z
UID:15328-1473811200-1474070399@ces.b2sg.org
SUMMARY:Wellcome Genome Campus: Single Cell Genomics 2016
DESCRIPTION:Building on the success of previous single cell genomics meetings\, this year’s meeting will be held at the Wellcome Genome Campus\, Hinxton\, UK. \n\n\n\nSingle cell genomics is rapidly emerging as a revolutionary technology transforming many fields of biological research\, including immunology and cancer. Through its many applications (e.g. single cell genome sequencing\, single cell transcriptomics\, and various single cell epigenetic profiling approaches)\, researchers can characterize the genetic and functional properties of individual cells in their native conditions\, leading to numerous experimental and clinical opportunities. \nAs technology is developing\, many critical questions are arising: \n\nWhich technologies are going to set the standard in the field?\nHow many cells needed to be sampled? How should sampling be designed and optimized?\nHow can the behaviour of groups of hundreds or thousands of single cells be analysed and modelled?\nWhat is the importance of modelling when precise single-cell-states are available?\nHow can single cell genomics and epigenomics be integrated?\nWhat are the immediate implications for immunology\, cancer research and germ cells?\n\nThese questions will be the focus of discussions at this year’s meeting. This conference will bring together biologists\,  methods developers\, computational modellers and genomics researchers interested in understanding biological variation at the single cell level.
URL:https://ces.b2sg.org/event/wellcome-genome-campus-single-cell-genomics-2016/
LOCATION:Wellcome Genome Campus\, Hinxton\, Camebridge\, United Kingdom
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/Wellcome-Genome-Campus.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160913
DTEND;VALUE=DATE:20160918
DTSTAMP:20160105T222345Z
CREATED:20151230T051245Z
LAST-MODIFIED:20160105T222345Z
UID:12204-1473724800-1474156799@ces.b2sg.org
SUMMARY:Epigenetics and Chromatin
DESCRIPTION:You are cordially invited to participate in the third Cold Spring Harbor Laboratory meeting on Epigenetics & Chromatin. The opening session will begin at 7:30 pm on Tuesday\, September 13 and the meeting will end after lunch on Saturday\, September 17\, 2016. As currently planned\, the program will have eight sessions devoted to oral presentations\, together with three poster sessions for presentations which cannot be accommodated in the formal sessions. Selection of talks for the oral sessions will be made by the organizers in conjunction with the session chairpersons\, from the submitted abstracts.
URL:https://ces.b2sg.org/event/epigenetics-and-chromatin/
LOCATION:Unnamed Venue\, Cold Spring Harbor\, NY\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/CSH.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160908
DTEND;VALUE=DATE:20160910
DTSTAMP:20160807T150339Z
CREATED:20160625T122255Z
LAST-MODIFIED:20160807T150339Z
UID:16199-1473292800-1473465599@ces.b2sg.org
SUMMARY:2nd Annual Epigenetics Discovery Congress
DESCRIPTION:The 2nd Annual Epigenetics Discovery Congress taking place on 8-9 September\, 2016 in London – UK will gather researchers\, academics and industry professionals working in epigenetic research to avail an opportunity to explore the potential of epigenetics. The congress will contribute towards novel and existing therapeutics\, current progress and trends in the inclusion of epigenetics in drug discovery and development. \nThe Cancer Epigenetics Society is a Supporting Association for this meeting\, and our members are eligible for a 40% discount on registration fees. Please contact the Cancer Epigenetics Society at info@ces.b2sg.org to claim the discount.
URL:https://ces.b2sg.org/event/2nd-annual-epigenetics-discovery-congress/
LOCATION:London Heathrow Marriot Hotel\,  Bath Road \, Heathrow Airport Hayes\, UB3 5AN\, United Kingdom
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2016/06/Epi_2016.jpg
ORGANIZER;CN="MnM Conferences":MAILTO:ajay.nimbalkar@mnmconferences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160908
DTEND;VALUE=DATE:20160910
DTSTAMP:20160426T194524Z
CREATED:20160426T182437Z
LAST-MODIFIED:20160426T194524Z
UID:15324-1473292800-1473465599@ces.b2sg.org
SUMMARY:abcam: RNA modifications and epitranscriptomics conference
DESCRIPTION:The meeting is aimed at bringing in students and postdocs as well as faculty involved in RNA modification and epitranscriptome research.  In addition to talks\, there will be a poster session and reception.\n \n\n\n\n\n\n\n\n\n\n\n\n\nTopics \n\nM6A mRNA methylation\nBiological functions of m6A RNA methylation\nDynamic RNA modifications\n​
URL:https://ces.b2sg.org/event/abcam-rna-modifications-and-epitranscriptomics-conference/
LOCATION:University of Chicago\, 5801 S Ellis Ave\, Chicago\, IL\, 60637\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/abcam1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160831
DTEND;VALUE=DATE:20160901
DTSTAMP:20160419T161802Z
CREATED:20160419T020949Z
LAST-MODIFIED:20160419T161802Z
UID:14924-1472601600-1472687999@ces.b2sg.org
SUMMARY:Translationale Onkologie (Translational Oncology)
DESCRIPTION:With the goal of further supporting collaborative translational cancer research projects at ‘Interdisciplinary Oncology Centers of Excellence’ and Comprehensive Cancer Centers\, the German Cancer Aid has decided to launch a third call for applications within the funding program ‘Translational Oncology’. Projects may be collaborative scientific projects (‘Verbundprojekte’) or innovative clinical trials\, which must be performed at more than two sites and necessitate close collaboration between several research groups. \nDuration of funding: – \nCoverd costs:  €7.000.000 annually \nNationality: At least one research group must be located at an ‘Interdisciplinary Oncology Center of Excellence’ funded by the German Cancer Aid.
URL:https://ces.b2sg.org/event/translationale-onkologie/
LOCATION:KY
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/deutsche-Krebshilfe.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160827
DTEND;VALUE=DATE:20160831
DTSTAMP:20160802T022230Z
CREATED:20160426T181215Z
LAST-MODIFIED:20160802T022230Z
UID:15320-1472256000-1472601599@ces.b2sg.org
SUMMARY:EMBL Conference: Transcription and Chromatin
DESCRIPTION:The EMBL Transcription and Chromatin meeting has a long-standing tradition in shaping the field of transcriptional regulation. The meeting brings together leading experts covering all aspects of transcription from cis-regulatory function\, long range regulation\, 3-dimensional looping\, the basal transcriptional machinery\, RNA polymerase regulation and function\, nucleosome positioning\, chromatin modifications\, chromatin remodelling\, and epigenetic inheritance of transcriptional silencing. The meeting contains many talks selected from the abstracts that are interspersed with invited speakers\, discussing the latest breakthroughs in transcriptional regulation. \n\n\n\n\n\n\nAims\nThe conference is designed to promote interactive discussions at both the talks and poster sessions. Given the excellent line up of speakers and the meeting’s outstanding reputation\, this is a ‘must’ attend for anyone interested in cutting edge research in transcription. \nTopics\n\nActivators\, enhancer function\, evolution and modelling\nLong range transcriptional regulation and enhancers\nGeneral basal transcriptional machinery\nPol II function\, pausing and the role of RNA in transcription\nChromatin modifications and transcription\nTranscriptional regulation during cell fate decisions – stem cell reprogramming and normal embryonic development
URL:https://ces.b2sg.org/event/embl-conference-transcription-and-chromatin/
LOCATION:EMBL\, Heidelberg\, Germany
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/EMBL-logo--e1525286945880.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160728
DTEND;VALUE=DATE:20160901
DTSTAMP:20160802T011734Z
CREATED:20160728T154017Z
LAST-MODIFIED:20160802T011734Z
UID:16749-1469664000-1472687999@ces.b2sg.org
SUMMARY:Assistant or Associate Professor/Staff level in Pediatric Research
DESCRIPTION:The Pediatric Institute of the Cleveland Clinic invites applications for new faculty positions at the Assistant or Associate Professor/Staff level. Exceptional candidates at the Professor/Staff level will also be considered. The positions will be based in the Lerner Research Institute of the Cleveland Clinic with a primary focus on basic or translational research. \nApplicants should have a M.D.\, Ph.D.\, D.V.M. or equivalent degree with postdoctoral training and show exceptional promise for an independent career in academic science. The Pediatric Institute is seeking individuals with a special interest in basic cellular and molecular processes\, and/or translational studies. \nAreas of special interest include\, but are not limited to: \nLung \nKidney \nPediatric Care \nGastrointestinal \nObesity and Diabetes \nMicrobiology \nEpigenetics \nAutism \nMicrobiology \nEnvironmental sciences \nNanotechnology \nImmunology \nThe successful candidate is expected to establish an innovative\, extramurally funded research program. The new faculty member will join a collaborative\, interdisciplinary group of investigators. Interactions with excellent clinical programs are readily available and provide the potential to develop multi-disciplinary and translational research programs. The Lerner Research Institute has a strong tradition of collaborative research\, and offers established programs for pre- and post-doctoral M.D. and Ph.D. trainees. Outstanding facilities and generous start-up funds are available. Salary will be commensurate with academic credentials and experience. \nThe Cleveland Clinic embraces diversity. Women\, underrepresented minorities and people with disabilities are strongly encouraged to apply. \nAt Cleveland Clinic Children’s\, every child receives world-class care. At our main campus in the heart of Cleveland\, Ohio\, as well as at our community hospitals and Family Health Centers located throughout northern Ohio\, children and families receive compassionate care from nationally and internationally renowned pediatricians and pediatric sub-specialists. \nMore than 300 pediatric medical and surgical specialists staffing 429 inpatient beds and 43 outpatient clinics forming the Cleveland Clinic Children’s network\, providing over 650\,000 outpatient visits\, 17\,000 hospital admissions\, 10\,000 surgeries\, and accepting over 1\,400 hospital transfers per year. \nMore than 100 pediatric physicians are recognized annually as being among the “Best Doctors in America.” \nCleveland Clinic Children’s has consistently ranked among the “Best Children’s Hospitals” by U.S. News and World Report . \nOur pediatric neurology and neurosurgery program ranked as the best in Ohio and among the top programs in the United States. \nOur pediatric gastroenterology program ranks among the top 10 programs in the United States according to U.S. News and World Report. \nCleveland Clinic is pleased to be an equal employment/affirmative action employer: Women/Minorities/Veterans/Individuals with Disabilities. \nSmoke/drug free environment. \n\n\n 
URL:https://ces.b2sg.org/event/assistant-or-associate-professorstaff-level-in-pediatric-research/
LOCATION:Cleveland Clinic\, 9620 Carnegie Ave\, Cleveland \, OH\, 44195\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/CCF-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160728
DTEND;VALUE=DATE:20160901
DTSTAMP:20160802T011421Z
CREATED:20160728T151656Z
LAST-MODIFIED:20160802T011421Z
UID:16744-1469664000-1472687999@ces.b2sg.org
SUMMARY:Post-Doctoral Research Fellow\, Cancer Genetics\Epigenetics
DESCRIPTION:Cures Start Here. At Fred Hutchinson Cancer Research Center\, home to three Nobel laureates\, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent\, diagnose and treat cancer\, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy\, which harnesses the power of the immune system to treat cancer. An independent\, nonprofit research institute based in Seattle\, Fred Hutch houses the nation’s first and largest cancer prevention research program\, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.  \nResponsibilities \nA postdoctoral position is available in the MacPherson Lab at Fred Hutchinson Cancer Research Center. The project will focus on small cell lung cancer (SCLC)\, a neuroendocrine tumor type that exhibits initial sensitivity to chemotherapy but invariable emergence of chemoresistance. Our lab is interested in linking specific gene mutations in SCLC to therapeutic vulnerabilities. We have developed a panel of new mouse models that can be used in this effort. With our clinical collaborators\, we are also generating patient derived xenograft models of SCLC. The project will be focused on chromatin regulators in SCLC and is particularly well suited to individuals with experience or interest in epigenetics/chromatin biology and cancer. In addition to in vivo studies\, the project will employ cell based screening to link specific SCLC-mutated genes to genetic vulnerabilities. The project will have a therapeutic component\, testing the efficacy and molecular mechanisms underlying new potential targeted therapy for SCLC. \nThe candidate will lead efforts to link SCLC gene mutations to therapeutic vulnerabilities\, combining in vivo studies with cell based screening and molecular analyses. The candidate should be able to drive an individual project but also be highly collaborative. \nQualifications \nWe are looking for a highly motivated individual with a PhD or MD and interests in cancer genetics\, mouse models\, epigenetics and therapeutics. A strong foundation in molecular and cell biology is essential. The candidate should be independent\, enthusiastic and scientifically rigorous.
URL:https://ces.b2sg.org/event/post-doctoral-research-fellow-cancer-geneticsepigenetics/
LOCATION:University of Miami\, 1320 S Dixie Hwy\, Coral Gables\, FL\, 33146\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/fred_hutch.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160728
DTEND;VALUE=DATE:20160901
DTSTAMP:20160728T135755Z
CREATED:20160728T135652Z
LAST-MODIFIED:20160728T135755Z
UID:16738-1469664000-1472687999@ces.b2sg.org
SUMMARY:Postdoctoral Scholar in Computational Biology and Epigenetics
DESCRIPTION:Postdoctoral Scholar position available for highly motivated candidates to join the Department of Emergency Medicine at Stanford University School of Medicine starting in September 2016 to investigate epigenetic regulation of innate immunity using high throughput epigenetic and molecular biology tools in order to discover and translate novel biomarkers for systemic infectious disease diagnosis and prognosis\, screen for targeted therapies\, and understand their underlying mechanisms of action in disease pathogenesis. \n Qualifications:\n• Ph.D. degree with in computational biology\, bioinformatics\, or immunology required.\n• Prior training or degree received from US/UK/Canadian academic institution required.\n• Knowledge and experience with various bioinformatic and biostatistical analysis tools are required.\n• Relevant prior hands-on experience in state-of-the-art methods such as Next Generation Sequencing (ChiP-Seq\, RNASeq\, etc.) and its data analysis\, array-based miRNA/gene expression analysis\, and non-coding RNA work will be given preference\n• Must possess excellent writing and communication skills\, a solid record of peer-reviewed publications\, commitment to drive scientific projects\, motivation for high impact\, high quality research\, ability to work closely with an interdisciplinary research team.\n• Applicants must be able to learn and develop new skills as required for the studies. Ability to work independently is expected. \nStanford University is an Equal Opportunity/Affirmative Action Employer. \nSalary commensurate with experience.\nTo apply for this position\, please send email to Dr. Samuel Yang at syang5@stanford.edu
URL:https://ces.b2sg.org/event/postdoctoral-scholar-in-computational-biology-and-epigenetics/
LOCATION:Stanford University\, School of Medicine\, 291 Campus Drive\, Stanford\, CA\, 94305\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/Stanford_School_of_Medicine.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160728
DTEND;VALUE=DATE:20160901
DTSTAMP:20160802T012105Z
CREATED:20160728T130258Z
LAST-MODIFIED:20160802T012105Z
UID:16737-1469664000-1472687999@ces.b2sg.org
SUMMARY:Postdoctoral Position in Stem Cell Biology and Cancer Epigenetics
DESCRIPTION:Job Description \nAn academic postdoctoral associate position is available in the laboratory of Dr. Jennifer Trowbridge to study epigenetic mechanisms governing hematopoietic stem cell lineage commitment\, and how deregulation of epigenetic modifications leads to myeloproliferative disorders including leukemia (http://trowbridgelab.com).\nThe Jackson Laboratory (JAX) offers a unique research and training environment characterized by multidisciplinary scientific collaboration\, unparalleled mouse resources\, outstanding core services\, and is located adjacent to Acadia National Park in coastal Maine. Translational research collaborations in genomics-based\, personalized medicine are fostered through our new JAX Genomic Medicine campus in Farmington\, CT. In addition to lab-based training\, JAX has developed a unique program for trainees to expand their professional skills in science communication\, entrepreneurship\, teaching\, mentoring and laboratory management to best prepare postdocs for future career opportunities. \nRequired Skills \nAbility to plan\, execute and analyze an independent research project as well as exceptional verbal and written communication skills. Preference given to self-motivated and career oriented individuals. \nRequired Experience \nA Ph.D. in biological or related sciences is required\, and a strong training background in molecular biology\, cell biology and/or epigenetics is preferred.\nApply by submitting a cover letter describing past research accomplishments\, research interests and career aspirations\, a current CV\, and the names of three references\, as one PDF file. \nAll qualified applicants will receive consideration for employment without regard to race\, color\, religion\, sex\, national origin\, disability or protected veteran status. \nJob Location: Bar Harbor\, Maine\, United States \nPosition Type: Full-Time/Regular \nSalary: 40\,000.00 – 60\,000.00 USD \n 
URL:https://ces.b2sg.org/event/postdoctoral-position-in-stem-cell-biology-and-cancer-epigenetics/
LOCATION:Jackson Laboratory\, 600 Main Street\, Bar Harbor\, ME\, 04609\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/Jackson-Lab.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160728
DTEND;VALUE=DATE:20160901
DTSTAMP:20160802T013332Z
CREATED:20160728T125712Z
LAST-MODIFIED:20160802T013332Z
UID:16736-1469664000-1472687999@ces.b2sg.org
SUMMARY:Postdoctoral Associate - Genome Technologies
DESCRIPTION:GENERAL SUMMARY \nThe Post-Doctoral Associate in Genome Technologies will develop molecular biology and sequencing applications to characterize the genome\, transcriptome\, & epigenetic changes as well as chromatin biology pertinent to disease conditions\, organismic response to environment changes and developmental cue. The research and developmental projects will be centered on sequencing based genome\, transcriptome and chromatin characterization. \n\nThe position will have a significant role in setting up novel\, cutting edge sequencing methods and platforms\, and will have the opportunity to work with various staff throughout The Jackson Laboratory. \n\n\nKEY RESPONSIBILITIES \n\nEvaluate the nature of the biological challenges and design molecular biological approaches\nPerform relevant experiments including the development and implementation of new sequencing or genomics methods to address critical biological questions\nParticipate in the development and implementation of wet lab protocols\nProvide technical and analytical interpretation of data\nImprove existing protocols & methods and implement new tools for general use\nMay also provide technical training and support to external collaborators\n\n\n\nREQUIRED SKILLS  \n\nAbility to drive projects and derive new ideas\nAbility to contribute publications and present data and analysis in scientific meetings\nMust recognize and understand the key challenges and opportunities in the field of genome technologies and sequencing applications surrounding areas critical to JAX’s core mission.\n\n  \n  \nMINIMUM QUALIFICATIONS \n\nPh.D. training in relevant area\n\n\nJob Location: Farmington\, Connecticut\, United States \nPosition Type: Full-Time/Regular \n 
URL:https://ces.b2sg.org/event/postdoctoral-associate-genome-technologies/
LOCATION:Jackson Laboratory\, 600 Main Street\, Bar Harbor\, ME\, 04609\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/Jackson-Lab.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160728
DTEND;VALUE=DATE:20160901
DTSTAMP:20160802T014509Z
CREATED:20160728T124418Z
LAST-MODIFIED:20160802T014509Z
UID:16732-1469664000-1472687999@ces.b2sg.org
SUMMARY:Faculty Positions - The Jackson Laboratory\, Bar Harbor\, Maine
DESCRIPTION:Job Description\n\nThe Jackson Laboratory for Mammalian Genetics\, in Bar Harbor\, Maine\, is inviting applications for Assistant\, Associate and Full Professors. Faculty on the Bar Harbor campus use genetic and genomic approaches to conduct basic research on fundamental biological problems and mechanisms of disease with emphasis on the mouse as a model system. Faculty members are being recruited for research in diverse areas\, including: \n  \n\nCancer Biology and Cancer Genomics\nComputational Biology and Bioinformatics\nDevelopmental and Reproductive Biology\nGenomic Editing and Engineering\nImmunology and Infectious Diseases\nMetabolic Disorders and Genetics of Aging\nNeurology and Neurobiology\nStatistical and Systems Genetics\nTrans-generational Inheritance and Epigenetics\n\n  \nThe Jackson Laboratory offers a uniquely collaborative scientific research environment. Faculty are supported by outstanding scientific services\, unparalleled mouse and genomic resources\, postdoctoral and predoctoral training programs\, and numerous courses and conferences centered on the mouse as a genetic model for human biology and disease. \n \nRequired Experience\n\nCandidates must have a Ph.D.\, M.D.\, or D.V.M. degree and relevant postdoctoral training with an exceptional record of research accomplishment\, and the ability to develop a competitive\, independently funded research program.  Opportunities are available for shared mentorship of trainees\, and integration with The Jackson Laboratory campuses in Connecticut and California. \n  \nApplicants should submit a curriculum vitae and a concise statement of research interests and plans as one document\, using this link.  In addition\, please arrange to have three letters of reference sent to:  facultyjobs@jax.org \n \nJob Location\nBar Harbor\, Maine\, United States\nPosition Type\nFull-Time/Regular
URL:https://ces.b2sg.org/event/faculty-positions-the-jackson-laboratory-bar-harbor-maine/
LOCATION:Jackson Laboratory\, 600 Main Street\, Bar Harbor\, ME\, 04609\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/Jackson-Lab.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160710
DTEND;VALUE=DATE:20160716
DTSTAMP:20160625T123423Z
CREATED:20160426T174955Z
LAST-MODIFIED:20160625T123423Z
UID:15318-1468108800-1468627199@ces.b2sg.org
SUMMARY:FASEB: Dynamic DNA Structures in Biology
DESCRIPTION:For decades after its discovery\, genomic DNA was believed to exist only as a right-handed\, double helix known as B-DNA.  Its sole functions were to serve as a template for RNA synthesis or as a template for the production of identical duplexes during chromosome replication.  These core beliefs were shaken by the discovery that DNA is covalently modified and packaged into chromatin\, and that the molecule can form an enormous variety of non-B alternative structures\, including cruciforms\, a left-handed helix\, three- and four-stranded helices\, and slip-strand configurations.  Transient denaturation of the duplex during all major DNA transactions (replication\, transcription\, repair and recombination) requires chromatin modifications and promotes dynamic transitions to non-B DNA structures.  Furthermore\, repetitive DNA sequences\, which are highly over-represented in genomic DNA\, are particularly prone to structural transitions.  Studies conducted in many labs worldwide have confirmed that structural transitions are not only central to normal functions of the genome\, but also are responsible for occasional malfunctioning that leads to a disease state.  The most striking example is expansion of structure-prone DNA repeats\, which is responsible for more than thirty hereditary neurological and developmental diseases. \n\n\n\n\n\n\n\n\n\nThis SRC is the fourth meeting on Dynamic DNA Structures in Biology\, a highly interactive meeting that brings together a diverse\, international community of researchers who maintain a “DNA-centric” view of basic biological processes.  Attendees will include those interested in disease-causing repeat expansions\, chromatin dynamics\, chromosome fragility related to transcription and replication\, and the biological roles of unusual\, non-B DNA structures.  Morning and evening scientific sessions will feature established and new investigators\, and ample time for discussion will be incorporated into the program.  In addition\, short talks chosen from submitted abstracts will be included in session\, with preference given to trainees.  Afternoon poster sessions will further foster the exchange of ideas and facilitate the establishment of new collaborations.  It is anticipated that funds will be available to support the attendance of young investigators and trainees.
URL:https://ces.b2sg.org/event/faseb-dynamic-dna-structures-in-biology/
LOCATION:Horowitz Performing Arts Hall and Nita Choukas Theater\,  Long Walk 10\,  Saxtons River\, VT\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/FASEB.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160710
DTEND;VALUE=DATE:20160714
DTSTAMP:20160625T123308Z
CREATED:20160426T171857Z
LAST-MODIFIED:20160625T123308Z
UID:15310-1468108800-1468454399@ces.b2sg.org
SUMMARY:21st INTERNATIONAL CHROMOSOME CONFERENCE
DESCRIPTION:It is a great pleasure to announce that the 21st International Chromosome Conference edition will take place in Foz do Iguaçu\, Brazil\, on July 10-13\, 2016. This will be the first time that the ICC will be held in South America. Foz do Iguaçu (Foz)\, is a desirable location in Brazil due to its beautiful nature\, human cultural diversity\, and easy access to several South American countries. Foz ICC 2016 is an excellent opportunity to bring exciting chromosome related topics and new technologies together for discussion under the view of the most outstanding chromosome biologists. \n 
URL:https://ces.b2sg.org/event/21st-international-chromosome-conference/
LOCATION:Rafain Palace Hotel & Convention Center\,  Foz do Iguaçu\, Brazil
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/ICC.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160706
DTEND;VALUE=DATE:20161101
DTSTAMP:20160706T183508Z
CREATED:20160706T181829Z
LAST-MODIFIED:20160706T183508Z
UID:16337-1467763200-1477958399@ces.b2sg.org
SUMMARY:PhD in Epigenetics/Cancer (Brussels\, Belgium)
DESCRIPTION:A PhD position is available in the Laboratory of Cancer Epigenetics headed by Prof. François Fuks at the Université libre de Bruxelles (ULB)\, Brussels\, Belgium. \nYou will be expected to conduct cancer research in epigenetics and epigenomics. Specifically\, you will investigate the mechanisms and functions of a novel epigenetic modification. The following recent publication has direct relevance to this project: Delatte B\, et al.\, Science. 2016; 351:282-5. Genetic\, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq\, ChIP-Seq\, Infinium Methylation) will be applied. The lab is running a Next Generation Sequencing (NGS) Illumina platform: EPICS\, and is part of the new ULB-Cancer Research Center (U-CRC) directed by Prof. Fuks\, providing an excellent scientific environment to conduct high profile research encompassing fundamental\, translational and clinical research. \nCandidates with a good first degree (BSc or MSc) in Biology\, Genetics\, Biochemistry or a related life science subject are all invited to apply. Preferred qualifications include excellent grades\, research talent (as proven by the master thesis) and personal ambition. Candidates are expected to have good academic writing and presentation skills. Screening of applications begins immediately and continues until an outstanding candidate is selected. \nThe position is funded for 3 years\, in the first instance. Screening of applications begins immediately and continues until an outstanding candidate is selected. The starting date is September 30\, 2016 at the latest. \nInformal enquiries\, a CV (including grades and class ranking)\, a motivation letter and names of three referees should be send to: Valentina Albarani (valentina.albarani@ulb.ac.be) \nLab website: http://www.ulb.ac.be/medecine/fukslab \nLab NGS platform EPICS: http://epics.ulb.be/ \nUniversity website: https://www.ulb.ac.be/ulb/presentation/uk.html \nSelected publications:\n– Delatte et al. Science 2016\n– Boumahdi et al. Nature 2014\n– Deplus et al. Cell Rep. 2014\n– Delatte et al. EMBO J. 2014\n– Deplus et al. EMBO J. 2013\n– Volkmar et al. EMBO J. 2012\n– Dedeurwaerder et al. EMBO Mol Med. 2011\n– Fuks F. Nature 2010\n– Villa et al. Cancer Cell 2007\n– Viré et al. Nature 2006
URL:https://ces.b2sg.org/event/phd-in-epigeneticscancer-brussels-belgium/
LOCATION:ULB\,  Université libre de Bruxelles Campus Erasme\, Anderlecht\, 1070\, Belgium
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2016/07/ULB-Epigenetics-lab.jpg
ORGANIZER;CN="ULB-Lab Cancer Epigenetics":MAILTO:epics@ulb.ac.be
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160705
DTEND;VALUE=DATE:20161101
DTSTAMP:20160706T183740Z
CREATED:20160705T174949Z
LAST-MODIFIED:20160706T183740Z
UID:16333-1467676800-1477958399@ces.b2sg.org
SUMMARY:Postdoc in Epigenetics/Cancer (Brussels\, Belgium)
DESCRIPTION:A postdoctoral position is immediately available in the Laboratory of Cancer Epigenetics headed by Prof. François Fuks (ULB – Université Libre de Bruxelles/Free University of Brussels\, Belgium). \nYou will be expected to conduct cancer research in epigenetics and epigenomics. Specifically\, you will investigate the mechanisms and functions of a novel epigenetic modification. The following recent publication has direct relevance to this project: Delatte B\, et al.\, Science. 2016; 351:282-5. Genetic\, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq\, ChIP-Seq\, Infinium Methylation) will be applied. The lab is running a Next Generation Sequencing (NGS) Illumina platform: EPICS (http://epics.ulb.be/) and is part of the new ULB-Cancer Research Center (U-CRC) directed by Prof. Fuks\, encompassing fundamental\, translational and clinical research and providing an excellent scientific environment to conduct high profile research.\nWe are looking for a highly motivated candidate with extensive experience in molecular and cell biology. Applicants should hold a PhD degree in Biochemistry/Molecular Biology or related disciplines (or have recently submitted their thesis with their defence scheduled) and have published (or about to publish) in a peer reviewed journal. Experience in epigenetics/epigenomics would be an asset. \nThe position is funded for 3 years. Screening of applications begins immediately and continues until an outstanding candidate is selected. Flexible starting date. \nInformal enquiries\, a CV\, a motivation letter and names of two referees should be send to: Valentina Albarani (valentina.albarani@ulb.ac.be) \nLab website: http://www.ulb.ac.be/medecine/fukslab\nLab NGS platform: http://epics.ulb.be/ \nSelected publications:\n– Delatte et al. Science 2016\n– Delatte et al. Science Rep. 2015\n– Boumahdi et al. Nature 2014\n– Deplus et al. Cell Rep. 2014\n– Delatte et al. EMBO J. 2014\n– Deplus et al. EMBO J. 2013\n– Volkmar et al. EMBO J. 2012\n– Dedeurwaerder et al. EMBO Mol Med. 2011\n– Fuks F. Nature. 2010\n– Epsztejn-Litman Nat Struct Mol Biol. 2008\n– Villa et al. Cancer Cell. 2007\n– Brenner & Fuks Dev Cell. 2007\n– Viré et al. Nature 2006\n– Brenner et al. EMBO J. 2005
URL:https://ces.b2sg.org/event/postdoc-in-epigeneticscancer-brussels-belgium/
LOCATION:ULB\,  Université libre de Bruxelles Campus Erasme\, Anderlecht\, 1070\, Belgium
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2016/07/ULB-Epigenetics-lab.jpg
ORGANIZER;CN="ULB-Lab Cancer Epigenetics":MAILTO:epics@ulb.ac.be
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160705
DTEND;VALUE=DATE:20160716
DTSTAMP:20160705T174131Z
CREATED:20160705T125627Z
LAST-MODIFIED:20160705T174131Z
UID:16313-1467676800-1468627199@ces.b2sg.org
SUMMARY:Post-Doctoral Research Fellow in Epigenetics (Mainz\, Germany)
DESCRIPTION:Institute of Molecular Biology (IMB)\, Mainz\, Germany\nDescription\nThe Institute of Molecular Biology (IMB) funded by the Boehringer Ingelheim Foundation is recruiting a Post-Doctoral Research Fellow in Epigenetics (#VTPD11) \nThe Institute of Molecular Biology (IMB) is a Centre of Excellence for Life Sciences\, funded by the Boehringer Ingelheim Foundation\, and located in Mainz\, Germany. Applications are invited for a postdoctoral researcher position in the laboratory of Dr. Vijay Tiwari.The successful applicant will contribute to internationally competitive research on epigenetic regulation of cell-fate specification during development. The group employs high-throughput epigenomics assays in combination with stem cell biology and neurobiology and cutting-edge epigenetics and molecular biology tools. The resulting datasets are analysed using computational and systems biology approaches to generate a comprehensive model of epigenetic regulation of gene expression during embryonic development. \nYou will \n\nStudy epigenetic mechanisms that regulate cell-type specification during neuronal development\nUtilize mouse embryonic stem cell differentiation and mouse as a model system\nObtain training in epigenetics\, gene regulation\, developmental biology and computational biology\nHave access to all IMB Core Facilities\nCollaborate with internal and external partners\nWork in close cooperation with a team of experimental and computational researchers to facilitate novel discoveries\n\nRequired Qualifications\n\nPhD in molecular biology\, neurobiology\, epigenetics\, biochemistry or developmental biology\, preferentially with a background in gene regulation\nStrong experience in at least one of the following areas: embryonic development\, stem cell biology\, neurobiology\, epigenetics\nAt least one first author paper in an international peer reviewed journal\nGood written and spoken English\nInterest in working in a multidisciplinary team\nCompetitiveness at the international level and willing to collaborate with internal and external collaborators as well as supporting other group members\n\nWe offer \n\nThe possibility to work on cutting-edge projects using state-of-the-art technology\nA stimulating\, diverse and international research environment\nAdvanced training opportunities\nCareer development\nCompetitive salary\nHighly motivated research team\n\nApplication details\nTo apply\, please email a cover letter\, your CV (in English)\, contact address of at least two professional referees and certificates of your degrees quoting Ref. No. #VTPD11 to personnel@imb-mainz.de. Informal inquires should be addressed to Dr. Vijay Tiwari (v.tiwari@imb-mainz.de). IMB is an equal opportunity employer. \nStarting date: 1st Aug 2016 or later; duration: Initially 2 years with option of further extension.\nDeadline for applications: 15th July 2016
URL:https://ces.b2sg.org/event/post-doctoral-research-fellow-in-epigenetics/
LOCATION:IMB Mainz\, Ackermannweg 4\, Mainz\, 55128 \, Germany
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/IMB_Mainz-1.png
ORGANIZER;CN="Dr. Vijay Tiwari":MAILTO:personnel@imb-mainz.de
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160704
DTEND;VALUE=DATE:20160901
DTSTAMP:20160705T174600Z
CREATED:20160704T233407Z
LAST-MODIFIED:20160705T174600Z
UID:16304-1467590400-1472687999@ces.b2sg.org
SUMMARY:Postdoctoral Research Associate in pancreatic cancer pathogenesis (Chapel Hill\, NC\, USA)
DESCRIPTION:Lineberger Comprehensive Cancer Center Research Laboratory aims to understand the pathogenesis and pharmacogenomics of pancreatic cancer in order to accelerate its treatment. Using a combination of molecular and genomic data\, and human in mouse models\, we have identified four core subtypes in pancreatic cancer with important biologic and clinical implications. We are seeking a postdoctoral associate in cancer genomics and personalized medicine who will be responsible for computational method development\, data analysis\, and experimental design. The qualified candidate will integrate information from a combination of sources\, including high throughput screens\, proteomic\, and next-gen sequencing data in order to generate and validate hypotheses of therapeutic relevance to pancreatic cancer. The ideal candidate will have excellent qualifications in a quantitative/computational field with a strong interest in learning cancer biology and/or wet bench techniques. Candidates from a largely wet bench background with a Ph.D. may be considered if the quantitative/computational background is excellent. \nTo be successful\, the candidate must have experience in and interested in developing several of the following skill-sets: thorough knowledge of cancer biology\, epigenetics\, proteomics\, and transcriptomics; familiarity with next-generation sequencing data analysis tools; experience working in Linux environments\, including batch job management on shared computing resources; familiarity with a variety of supervised and unsupervised classification techniques; proficiency in one or more statistical or scripting languages\, preferably R or MATLAB; knowledge of survival-based statistical analysis\, e.g. Cox regression and Kaplan-Meier analysis; working knowledge of best-practices for machine learning to avoid over fitting; familiarity with common experimental techniques in molecular biology; ability to communicate scientific material and collaborate well with computational and non-computational partners; excellent oral and written communication skills and the ability to perform both self-directed and guided research; outstanding personal initiative and the ability to work effectively as part of a team; willingness to assist in the mentorship and training of pre-doctoral researchersPh.D. in a quantitative/computational field or a Ph.D. with an equivalent certificate in a quantitative/computational field is required; have experience in handling large datasets and have applied/developed computational algorithms in the context of molecular biology; have a thorough understanding of common statistical tests and distributions; be able to collaborate with experimental team members for validation of computational results; be comfortable maintaining datasets\, as well as displaying and interpreting processed data for publication; work alongside domain experts in the optimization and development of experimental measurement platforms and protocols.
URL:https://ces.b2sg.org/event/postdoctoral-research-associate-in-pancreatic-cancer-pathogenesis/
LOCATION:University of North Carolina – UNC-Chapel Hill\, Chapel Hill\, NC\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/U_North_Carolina-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160629
DTEND;VALUE=DATE:20160630
DTSTAMP:20160419T152345Z
CREATED:20160419T020320Z
LAST-MODIFIED:20160419T152345Z
UID:14923-1467158400-1467244799@ces.b2sg.org
SUMMARY:Quality of Life Research Grant
DESCRIPTION:Quality of Life Research Grants have been created to support quality of life cancer research that has the potential to make a significant impact on the burden of disease in patients\, survivors and caregivers. These grants are intended to explore psychosocial\, survivorship\, symptom control\, supportive care and end-of-life issues\, research gaps\, needs and opportunities\, or models for survivorship care. The grants are meant to accelerate and focus the knowledge gained from scientific findings\, in the short or long term\, into outcomes that will result in the reduced burden or enhanced quality of life for cancer patients in Canada and elsewhere. \nDuration of funding: – \nCoverd costs: \nNationality: Canada
URL:https://ces.b2sg.org/event/quality-of-life-research-grant/
LOCATION:KY
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/canadian-cancer-society.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160626
DTEND;VALUE=DATE:20160629
DTSTAMP:20160426T173907Z
CREATED:20160426T173006Z
LAST-MODIFIED:20160426T173907Z
UID:15314-1466899200-1467158399@ces.b2sg.org
SUMMARY:Cell Symposium: Transcriptional Regulation in Development and Disease
DESCRIPTION:Transcriptional Regulation in Development and Disease will bring together researchers studying developmental biology and its disruption in disease with those examining the specific molecular and cellular mechanisms of transcriptional regulation.\n \n\n\n\nIn addition to the presentations from the invited speakers\, we are also eagerly anticipating hearing from you about emerging exciting discoveries that can be considered for presentation at the meeting in the form of short talks or posters on topics including: \n\nDevelopmental dynamics\nTranscriptional memory and plasticity\nNon-coding RNAs and retroelements\nChromatin structure and epigenetics\nStem cells and developing systems\nTools and techniques for in vivo analysis\n\nWe also hope you will take advantage of the chance to hear from Cell Press editors during our Author Workshop. This informal Q&A session is a great chance to get an editorial perspective on effectively communicating about your research.
URL:https://ces.b2sg.org/event/cell-symposium-transcriptional-regulation-in-development-and-disease/
LOCATION:Unnamed Venue\, Chicago\, IL\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/Cell-Symposium.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160619
DTEND;VALUE=DATE:20160625
DTSTAMP:20160419T161448Z
CREATED:20151230T050829Z
LAST-MODIFIED:20160419T161448Z
UID:12201-1466294400-1466812799@ces.b2sg.org
SUMMARY:FASEB meeting: Biological Methylation\, Fundamental Mechanisms in Health and Disease
DESCRIPTION:Conference Summary\nThis SRC is focused on  the role of Methylation Dynamics in nuclear and cytoplasmic biological processes and how this modification impacts development\, epigenetic cellular identity\, tissue homeostasis and disease. Studies looking at how this chemical modification impacts nucleic acid and protein function across model systems and in disease models will be presented. These topics will be complemented with presentations on how methylation states are established\, maintained\, interpreted and inter-converted\, along with their functional cellular consequences  and how this translates into developmental and disease states. Since methylation has become a major therapeutic target in recent years\, there will be a focus on the advancements in therapeutics and technologies used to quantitatively monitor this modification in cells and organisms. \nThis meeting will bring together an interdisciplinary group of scientists interested in how a small covalent modification can have such profound biological impact.  Invited speakers are experts in biological methylation from a variety of perspectives including cell and developmental biology\, molecular biology\, epigenetics/epigenomics\,  structural biology and chemical biology.  The conference will be structured to optimize interactions among all attendees\, with several poster sessions and technology workshops. A significant number of oral presentations will be chosen from poster abstracts submitted by trainees and junior faculty.  This conference will also be an excellent opportunity for scientists less familiar with methylation mediated signaling and epigenetics to learn how this rapidly evolving field could impact their research.
URL:https://ces.b2sg.org/event/biological-methylation-fundamental-mechanism-in-health-and-disease/
LOCATION:Lisbon Marriott Hotel\, Avenida dos Combatentes \, Lisboa (Lisbon) 1600-042 Portugal\, Lisbon\, Portugal
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/FASEB.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160617
DTEND;VALUE=DATE:20160618
DTSTAMP:20160419T151714Z
CREATED:20160419T020042Z
LAST-MODIFIED:20160419T151714Z
UID:14921-1466121600-1466207999@ces.b2sg.org
SUMMARY:Postdoctoral Fellowship grants
DESCRIPTION:PDF Grants seek to attract and support promising scientists embarking on careers dedicated to breast cancer research and who have no more than 3 years post-completion of their most recent clinical fellowship\, 5 years post-completion of their most recent residency (for physicians)\, or 5 years post-completion of their most recent Ph.D. By providing funding to outstanding postdoctoral/postgraduate fellows under the guidance of a mentor\, Komen seeks to ensure that a diverse pool of highly trained scientists will emerge as the next generation of leaders in the field of breast cancer research. PDF Grants provide support for research projects that have significant potential to advance our understanding of breast cancer\, lead to reductions in breast cancer incidence and/or mortality\, and move us toward the goal of a world without breast cancer. \nDuration of funding: 2-3 years \nCoverd costs:  Up to $180\,000 direct costs only ($60\,000 per year) \nNationality: not required to be a U.S. citizen or resident
URL:https://ces.b2sg.org/event/postdoctoral-fellowship-grants/
LOCATION:KY
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/susan-g-komen.png
END:VEVENT
END:VCALENDAR